NCI Networks

NCI Networks, officially known as National Clinical Investigation, is a leading South Korean contract research organization (CRO) specializing in clinical trial management and regulatory affairs. The company provides a comprehensive suite of services including clinical monitoring, data management, biostatistics, and medical writing for pharmaceutical and biotechnology clients. NCI Networks is particularly recognized for its expertise in navigating the South Korean regulatory landscape and managing multi-center clinical trials across various therapeutic areas. By leveraging a robust network of clinical investigators and research sites, the company facilitates efficient drug development and market entry for both domestic and international sponsors. Their services span from Phase 1 through Phase 4 clinical trials, as well as post-marketing surveillance and observational studies.